Sign up for the Race/Related Newsletter join a deep and provocative exploration of race identity and society with New York Times journalists. Get it sent to your inbox.
Sales rise 15.92% to Rs 3.35 crore
Net profit of Ishita Drugs & Industries rose 21.43% to Rs 0.17 crore in the quarter ended June 2022 as against Rs 0.14 crore during the previous quarter ended June 2021. Sales rose 15.92% to Rs 3.35 crore in the quarter ended June 2022 as against Rs 2.89 crore during the previous quarter ended June 2021. ParticularsQuarter EndedJun. 2022Jun. 2021% Var.Sales3.352.89 16 OPM %6.576.23 -PBDT0.260.22 18 PBT0.230.18 28 NP0.170.14 21Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
